首页 | 本学科首页   官方微博 | 高级检索  
     


The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening
Authors:Sarah Benafif  Holly Ni Raghallaigh  Eva McGrowder  Edward J. Saunders  Mark N. Brook  Sibel Saya  Reshma Rageevakumar  Sarah Wakerell  Denzil James  Anthony Chamberlain  Natalie Taylor  Matthew Hogben  Barbara Benton  Lucia D’Mello  Kathryn Myhill  Christos Mikropoulos  Hywel Bowen-Perkins  Imran Rafi  Michelle Ferris  Andre Beattie  Shophia Kuganolipava  Tamsin Sevenoaks  Juliet Bower  Pardeep Kumar  Steven Hazell  Nandita M. deSouza  Antonis Antoniou  Elizabeth Bancroft  Zsofia Kote-Jarai  Rosalind Eeles
Affiliation:1. Oncogenetics Team, Institute of Cancer Research, London, UK;2. Oncogenetics Team, Institute of Cancer Research, London, UK

The University of Melbourne, Melbourne, Victoria, Australia;3. Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK;4. Royal Surrey County Hospital NHS Foundation Trust, Surrey, UK;5. Shadbolt Park House Surgery, Worcester Park, UK;6. The Longcroft Clinic, Banstead, UK;7. Lane End Medical Group, Edgware, UK;8. Dorking Medical Practice, Dorking, UK;9. Medwyn Surgery, Dorking, UK;10. Brockwood Medical Practice, Dorking, UK;11. Leith Hill Practice, Dorking, UK;12. Magnetic Resonance Team, Institute of Cancer Research, London, UK;13. Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK

Abstract:
Keywords:prostate cancer  SNPs  screening  precision medicine  GWAS
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号